300
Participants
Start Date
November 7, 2017
Primary Completion Date
July 1, 2021
Study Completion Date
January 1, 2022
WES
136 bleeding related OMIM (Online Mendelian Inheritance in Man)-proved genes involved in haemostasis will be selected from Whole Exome Sequencing (WES)
Several assays
Patients will be approached by their own treating physician. Data will be collected through questionnaires, a clinical interview, a blood and saliva sample obtained from each participant, and thorough review of electronic patient records. All procedures are study related. In case a physician visit with the treating physician is already planned, or in case a venepuncture for regular diagnostics or treatment is already planned, this can be combined with the study procedures to prevent an extra visit.
RECRUITING
Academisch Medisch Centrum, Amsterdam
RECRUITING
University Medical Center Groningen (UMCG), Groningen
RECRUITING
Maxima Medisch Centrum, Eindhoven
RECRUITING
Maatricht UMC+, Maastricht
RECRUITING
Radboud university medical center, Nijmegen
RECRUITING
Erasmus MC, Rotterdam
RECRUITING
Haga hospital, The Hague
Collaborators (2)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Academisch Ziekenhuis Maastricht
OTHER
Erasmus Medical Center
OTHER
Maxima Medical Center
OTHER
Academisch Ziekenhuis Groningen
OTHER
UMC Utrecht
OTHER
Leiden University Medical Center
OTHER
Haga Hospital
OTHER
Radboud University Medical Center
OTHER